Rolling Stone, the onetime banner of the counterculture, had by 2021 devolved into a reliable mouthpiece for medical cartel orthodoxies.89 In October 2021, Rolling Stone announced that it had removed from its website a 2005 article linking mercury in vaccines to brain injuries in children. Rolling Stone also reported that Oklahomans overdosing on ivermectin horse dewormer were causing emergency rooms to be “so backed up that gunshot victims were having hard times getting” access to health facilities. An accompanying photo purported to depict a long line of ambulatory gunshot casualties seeking hospital admission to an Oklahoma emergency room already filled to capacity with dingbats poisoned by horse wormer.90
The Rolling Stone story91 spread like wildfire among the world’s reigning media outlets, including the Daily Mail, 92 Business Insider, Newsweek,93 Yahoo News, The Guardian,94 and The Independent,95 many of which rely on Gates Foundation largesse. MSNBC’s news host, Rachel Maddow, told her audience that “Patients are overdosing on ivermectin backing up rural Oklahoma hospitals, ambulances.”96
“Ivermectin is meant for a full-size horse,” she explained. She repeated that the victims first gullibly swallowed the false claims of antivaxxers before guzzling down horse dewormer. “The ERs are so backed up that gunshot victims were having hard times getting to facilities where they can get definitive care and be treated.”
The story, of course, was fraud. Days later, Oklahoma’s Sequoyah Northeastern Health System posted a categorical denial on its website, dismissing the entire story as mere fabrication. That Rolling Stone picture of the long lines was an Associated Press stock photo from the previous January, a photo of people waiting in line to get vaccines. As it turns out, not a single patient has been treated in Oklahoma for ivermectin overdose.
Instead of retracting the article, Rolling Stone simply posted an attention-dodging “update” at the top of the article reporting the hospital’s denial.97 The Guardian similarly published a nondescript update at the bottom of its article.98
The FDA doubled down with the claim that IVM may cause “serious harm,” is “highly toxic” and may cause “seizures,” “coma and even death.”99
As we shall see, these kinds of warnings are far more applicable to COVID shots. The CDC issued an emergency memo on August 26, 2021 warning doctors and pharmacists not to prescribe ivermectin.100
As molnupiravir’s debut approached, the war against IVM escalated. On September 23, the Colorado Department of Law issued a cease-and-desist order and fined a Loveland medical clinic $40,000 for “marketing and overstating the effectiveness of ivermectin.” And pharmacists still willing to dispense ivermectin faced a new problem. The wholesalers began dribbling out a few pills at a time, but not enough for even one prescription per week. All their diabolical tricks seemed the work of winks and nods and a powerful hidden hand, with no corporation or federal agency taking clear responsibility for carrying out a deliberate policy to suppress a life-saving drug.
On September 28, the New York Times introduced a new tactic: reporting that the demand for ivermectin among the crackpots trying to treat COVID had created a shortage for veterinary purposes, warning that—any day now—animals might begin to suffer.101
Peter McCullough laughs at the propaganda: “Ivermectin is a molecule that is miraculously effective against parasites and viral infections along multiple pathways and mechanisms of action. It’s a molecule. It doesn’t care if it’s used in a horse, or a cow, or a human. The rules of physics and chemistry are the same across species.”
Pierre Kory concurs. “Ivermectin has multiple properties. It operates against COVID along a multitude of separate pathways. In addition to being antiparasitic, it also has potent antiviral properties and even “protects against SARS-CoV-2 spike protein damage.”
The osteopath Dr. Joseph Mercola observed,102 “This idea that ivermectin is a horse dewormer that poses a lethal risk to humans is pure horse manure, shoveled at us in an effort to dissuade people from using a safe and effective drug against COVID-19. . . . The intent is clear. What our so-called health agencies and the media are trying to do is confuse people into thinking of ivermectin as a ‘veterinary drug,’ which simply isn’t true. Ultimately, what they’re trying to do is back up the Big Pharma narrative that the only thing at your disposal is the COVID shot.”
IV: REMDESIVIR
Anthony Fauci needed to use all his moxie and all his esoteric bureaucratic maneuvers—mastered during his half-century at NIH—to win FDA’s approval for his vanity drug, remdesivir. Remdesivir has no clinical efficacy against COVID, according to every legitimate study. Worse, it is deadly poisonous, and expensive poison at $3,000 for treatment.1 In fact, remdesivir’s wholesale cost is roughly 1,000x more costly than hydroxychloroquine and ivermectin. The challenge required Dr. Fauci to first sabotage HCQ and IVM. Under federal rules discussed earlier, FDA’s recognition of HCQ and IVM efficacy would automatically kill remdesivir’s ambitions for EUA designation. And even if Dr. Fauci somehow finagled an FDA license for remdesivir, demand for the product, which doctors were administering late in the disease, as it had to be given through an IV in the hospital, would plummet if either HCQ or IVM stopped the COVID-19 infections early.
Why would Dr. Fauci care to undermine any medicine that might compete with remdesivir? Might it have something to with NIAID and CDC having just spent $79 million2 developing remdesivir for Gilead, a company in which the Bill & Melinda Gates Foundation owns a $6.5 million stake?3,4 The BMGF is engaged in other large drug development deals with the company, including a cofunded $55 million investment in a malaria treatment being developed by Lyndra Therapeutics. Gates has also funded the promotion of Gilead’s Truvada in Kenya.5,6 Another Gilead partner, the US Army Medical Research Institute of Infectious Diseases at Ft. Detrick, Maryland (USAMRIID), where the drug was studied in monkeys, also contributed millions to remdesivir’s development.7 At the outset of the coronavirus plague, remdesivir was just another pharma-owned molecule that FDA had never approved as safe and efficacious for any purpose. In 2016, remdesivir demonstrated middling antiviral properties against Zika, but the disease disappeared before the expensive non-remedy got traction.8 After the Zika threat vanished, NIAID put some $6.9 million into identifying a new pandemic against which to deploy remdesivir. In 2018, Gilead entered remdesivir in a NIAID-funded clinical trial against Ebola in Africa.9